Results 51 to 60 of about 10,372,945 (317)
Interaction of Nanoparticles with Blood Components and Associated Pathophysiological Effects
, 2018 Nanotechnology currently plays a pivotal role in several fields and has enabled substan - tial advances in a relatively short time. In biomedicine, nanomaterials can be potentially employed as a tool for early diagnosis and an innovative mode of drug ...
G. D. L. Cruz +5 more
semanticscholar +1 more source
FoxO1 signaling in B cell malignancies and its therapeutic targeting
FEBS Letters, EarlyView.FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac +3 more
wiley +1 more source
Multi-Class Classification of Blood Cells -- End to End Computer Vision based diagnosis case study [PDF]
arXiv, 2021 The diagnosis of blood-based diseases often involves identifying and characterizing patient blood samples. Automated methods to detect and classify blood cell subtypes have important medical applications. Automated medical image processing and analysis offers a powerful tool for medical diagnosis.
arxiv
OncoTarget, 2017 Leukoreduction in blood units could prevent patients undergoing transfusions from transfusion-associated adverse reactions (TAARs) such as febrile nonhemolytic transfusion reactions (FNHTRs).
Chih-Chun Chang +7 more
semanticscholar +1 more source
FEBS Letters, EarlyView.Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects nearly one‐third of the global population and poses a significant risk of progression to cirrhosis or liver cancer. Here, we discuss the roles of hepatic dendritic cell subtypes in MASLD, highlighting their distinct contributions to disease initiation and progression, and their ...
Camilla Klaimi +3 more
wiley +1 more source
Scientific ReportsAdded safety measures coupled with the development and use of pathogen reduction technologies (PRT) significantly reduces the risk of transfusion-transmitted infections (TTIs) from blood products.
Joseph W. Jackson +7 more
doaj +1 more source
Spectrum of hemolytic transfusion reactions from tertiary cancer center over a 1-year period
Global Journal of Transfusion Medicine, 2023 Background and Objectives: Acute hemolytic transfusion reactions (HTRs) one of the serious adverse events manifesting within 24 h of blood transfusion. To review the adverse transfusion reactions in our cancer center over a 1-year period, especially HTR ...
Valathuparambil Jalaludheen Fathima +2 more
doaj +1 more source
Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia
FEBS Letters, EarlyView.This Review explores how the phosphoinositide 3‐kinase and protein kinase B pathway shapes B cell development and drives chronic lymphocytic leukemia, a common blood cancer. It examines how signaling levels affect disease progression, addresses treatment challenges, and introduces novel experimental strategies to improve therapies and patient outcomes.
Maike Buchner
wiley +1 more source
Revista Brasileira de Zootecnia, 2004 Foi conduzido um experimento, objetivando avaliar o efeito de dietas de baixo teor de proteína bruta, suplementadas com aminoácidos, sobre o desempenho de leitões machos castrados na fase inicial.
Gisele Cristina de Oliveira +4 more
doaj +1 more source
Acute Transfusion Reactions in Intensive Care Unit: A Retrospective Study [PDF]
Journal of Clinical and Diagnostic Research, 2014 Background: Blood transfusion is a frequent and integral part of critical care. Although life saving, it can occasionally be unsafe and result in a spectrum of adverse events.
Rajesh Kumar +4 more
doaj +1 more source